about
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisDissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional modelNeglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationOral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice.What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".Update in Mycobacterium tuberculosis lung disease 2014.MCL Plays an Anti-Inflammatory Role in Mycobacterium tuberculosis-Induced Immune Response by Inhibiting NF-κB and NLRP3 Inflammasome Activation.In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.Toxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCαCathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary TuberculosisImmunological consequences of strain variation within the Mycobacterium tuberculosis complex.Inhibiting Mycobacterium tuberculosis within and without.Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers.Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review.Gene Expression Signatures in Tuberculosis Have Greater Overlap with Autoimmune Diseases Than with Infectious Diseases.Exposed, but Not Protected: More Is Needed to Prevent Drug-Resistant Tuberculosis in Healthcare Workers and Students.Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PD.Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis.Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes.Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice.Harnessing the mTOR Pathway for Tuberculosis Treatment.The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis.Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets.The Nature and Evolution of Genomic Diversity in the Mycobacterium tuberculosis Complex.GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection.Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy.A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis.Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis
P2860
Q26746099-148A15C0-4E32-4EE7-889F-BA9FE27C9EC5Q28468572-EE64542D-E4D8-4B4E-9570-D2588972BC32Q28602660-55409860-A2E4-459D-9735-95C54402D307Q31037455-A613A8AF-58D1-4136-B74E-C183EDEEE7A3Q33679240-A1164DC9-B8BE-4DD4-A77C-F0F732CB1652Q33735642-A9737C0A-2201-4F6B-9D73-9EED376CD389Q33795068-8BFD7F35-2840-47C4-945B-A884468DE79CQ35960979-74548BDB-EF40-415D-BA3F-BE036CCF035CQ36006797-B0821097-E2F6-48B5-BC83-3BC29390E185Q36021134-96DE0E0E-82AD-4C3D-8364-0BFC3768CA4FQ36094210-B3D9AA99-8088-4E0E-8869-5DD77FF86118Q36173327-3737A14B-CE5D-4EB8-ABD3-57D7FFD38D07Q36261479-0DDEF223-9A16-4039-B22B-CF1D85FF27C9Q36487876-68CF0A14-82B0-474E-94CC-AE93D57CC1A8Q37717814-FCAB6EF2-F465-4851-B0E6-CF4933A359A3Q38965421-D2DA32CF-2E3F-4F23-A3AE-D647C0415DDBQ39038482-5FF94A3A-203C-4942-86D1-560B4F4DE72AQ39344161-40355B98-ADBF-4F94-BA6F-5D372422EFA1Q39437994-CC3737AB-C259-45E5-9486-804A41BA9992Q40115642-1E8187DA-4196-4908-8CD9-D2F0B8D46F04Q40697219-5241CDFB-53FC-4C8E-86EE-E76271211BE3Q41990715-AD371FC1-738C-43A1-8AB0-FEA598E99416Q47096875-E8025486-3553-499A-B9DF-40071B3CF9B7Q47367907-EB77A070-C22A-4B72-BAD0-B9BAB2BB4ED2Q47548481-8563D28C-620D-4E66-A5D0-3D8597C19B82Q48355478-31A0E8AB-6B21-41B3-92D9-2463C13553C3Q49417693-C2E47143-7F15-412B-BFAC-03375D6DF4B0Q49637506-0FEFC0C3-CA28-4A05-BE67-5C61AFAE4BAFQ49807763-EC0517F7-6D3E-463F-873E-4BFB948F751BQ50108000-2E0CF936-7A45-42D7-9E35-5EEABA5695B5Q55303373-AD5DEEB5-4162-4409-90D7-2D7CC6C6AEECQ55343159-929B85DD-7E71-49BC-9E53-016B3E4384F0Q55378112-B0FDBF1A-4213-486A-B662-17EF946608E1Q58769155-B8AAC985-692B-4F2E-BFF4-90CEDC8FCAF2
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Towards host-directed therapies for tuberculosis.
@en
type
label
Towards host-directed therapies for tuberculosis.
@en
prefLabel
Towards host-directed therapies for tuberculosis.
@en
P2093
P50
P356
P1476
Towards host-directed therapies for tuberculosis.
@en
P2093
Alberto Garcia-Basteiro
Almoustapha Maiga
Andrie Steyn
Bassirou Diarra
Clara Menendez
Elirehema Mfinanga
Eusebio Macete
Gavin Churchyard
Gibson Kibiki
Gill Craig
P2888
P304
P356
10.1038/NRD4696
P50
P577
2015-07-17T00:00:00Z